UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 98

Sortiert nach

Management of adverse events associated with idelalisib treatment: expert panel opinion

Leukemia & lymphoma, 2015-10, Vol.56 (10), p.2779-2786

2015

Link zum Volltext

Verfügbarkeit prüfen

G-protein coupled receptor 34 activates Erk and phosphatidylinositol 3-kinase/Akt pathways and functions as alternative pathway to mediate p185Bcr-Abl-induced transformation and leukemogenesis

Leukemia & lymphoma, 2015-07, Vol.56 (7), p.2170-2181

2015

Link zum Volltext

Verfügbarkeit prüfen

Ibrutinib, idelalisib and obinutuzumab for the treatment of patients with chronic lymphocytic leukemia: three new arrows aiming at the target

Leukemia & lymphoma, 2015-12, Vol.56 (12), p.3250-3256

2015

Link zum Volltext

Verfügbarkeit prüfen

Posttranscriptional regulation of the p85α adapter subunit of phosphatidylinositol 3-kinase in human leukemia cells

Leukemia & lymphoma, 2011-03, Vol.52 (3), p.467-477

2011

Link zum Volltext

Verfügbarkeit prüfen

Novel phosphatidylinositol 3-kinase inhibitor BKM120 enhances the sensitivity of multiple myeloma to bortezomib and overcomes resistance

Leukemia & lymphoma, 2017-02, Vol.58 (2), p.428-437

2017

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of constitutive phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase phosphorylation in acute myeloid leukemia

Leukemia & lymphoma, 2015-08, Vol.56 (8), p.2281-2288

2015

Link zum Volltext

Verfügbarkeit prüfen

Dual inhibition of phosphatidylinositol 3-kinase/mammalian target of rapamycin and mitogen activated protein kinase pathways in non-Hodgkin lymphoma

Leukemia & lymphoma, 2015-01, Vol.56 (1), p.263-266

2015

Link zum Volltext

Verfügbarkeit prüfen

B-cell activating factor-receptor specific activation of tumor necrosis factor receptor associated factor 6 and the phosphatidyl inositol 3-kinase pathway in lymphoma B cells

Leukemia & lymphoma, 2014-08, Vol.55 (8), p.1884-1892

2014

Link zum Volltext

Verfügbarkeit prüfen

NOTCH and phosphatidylinositide 3-kinase/phosphatase and tensin homolog deleted on chromosome ten/AKT/mammalian target of rapamycin (mTOR) signaling in T-cell development and T-cell acute lymphoblastic leukemia

Leukemia & lymphoma, 2011-07, Vol.52 (7), p.1200-1210

2011

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of class II phosphoinositide 3-kinase gamma expression by p185(Bcr-Abl) contributes to impaired chemotaxis and aberrant homing of leukemic cells

Leukemia & lymphoma, 2010-06, Vol.51 (6), p.1098

2010

Link zum Volltext

Verfügbarkeit prüfen

Posttranscriptional regulation of the p85α.alpha; adapter subunit of phosphatidylinositol 3-kinase in human leukemia cells

Leukemia & lymphoma, 2011-03, Vol.52 (3), p.467-477

2011

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase inhibits GM-CSF-dependent colony formation of CD34+ hematopoietic progenitor cells

Leukemia & lymphoma, 2008-06, Vol.49 (6), p.1206-1208

2008

Link zum Volltext

Verfügbarkeit prüfen

Up-regulated autophagy by endogenous high mobility group box-1 promotes chemoresistance in leukemia cells

Leukemia & lymphoma, 2012-02, Vol.53 (2), p.315-322

2012

Link zum Volltext

Verfügbarkeit prüfen

Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1

Leukemia & lymphoma, 2011-09, Vol.52 (9), p.1758-1769

2011

Link zum Volltext

Verfügbarkeit prüfen

The role of PI3K inhibitors in the treatment of malignant lymphomas

Leukemia & lymphoma, 2021-02, Vol.62 (3), p.517-527

2021

Link zum Volltext

Verfügbarkeit prüfen

BCR/ABL Regulation of PI-3 Kinase Activity

Leukemia & lymphoma, 1996, Vol.23 (5-6), p.473-476

1996

Link zum Volltext

Verfügbarkeit prüfen

Activating somatic mutations in diffuse large B-cell lymphomas: lessons from next generation sequencing and key elements in the precision medicine era

Leukemia & lymphoma, 2015-05, Vol.56 (5), p.1213-1222

2015

Link zum Volltext

Verfügbarkeit prüfen

Homoharringtonine inhibits the AKT pathway and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells

Leukemia & lymphoma, 2008-01, Vol.49 (10), p.1954-1962

2008

Link zum Volltext

Verfügbarkeit prüfen

Pan-PI3Ki targets multiple B-ALL microenvironment interactions that fuel systemic and CNS relapse

Leukemia & lymphoma, 2021-09, Vol.62 (11), p.2690-2702

2021

Link zum Volltext

Verfügbarkeit prüfen

Bryostatin Induces Protein Kinase C Modulation, Mcl-1 Up-Regulation and Phosphorylation of Bcl-2 Resulting in Cellular Differentiation and Resistance to Drug-induced Apoptosis in B-cell Chronic Lymphocytic Leukemia Cells

Leukemia & lymphoma, 2004-05, Vol.45 (5), p.997-1008

2004

Link zum Volltext

Verfügbarkeit prüfen

cAMP/PKA-mediated Regulation of Erythropoiesis

Leukemia & lymphoma, 2003-11, Vol.44 (11), p.1893-1901

2003

Link zum Volltext

Verfügbarkeit prüfen

PI3-Kinase Regulates Survival of Chronic Lymphocytic Leukemia B-Cells by Preventing Caspase 8 Activation

Leukemia & lymphoma, 2004-08, Vol.45 (8), p.1519-1529

Plate, Janet MD

2004

Link zum Volltext

Verfügbarkeit prüfen

Co-targeting intracellular pH and essential amino acid uptake cooperates to induce cell death of T-ALL/LL cells

Leukemia & lymphoma, 2018-02, Vol.59 (2), p.460-468

2018

Link zum Volltext

Verfügbarkeit prüfen

Synergistic cytotoxicity of busulfan, melphalan, gemcitabine, panobinostat, and bortezomib in lymphoma cells

Leukemia & lymphoma, 2016-11, Vol.57 (11), p.2644-2652

2016

Link zum Volltext

Verfügbarkeit prüfen

Leptin receptor expression and its association with PI3K/AKT signaling pathway in diffuse large B-cell lymphoma

Leukemia & lymphoma, 2010-07, Vol.51 (7), p.1305-1314

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 98

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis Online

Zeitschrift / SerieLeukemia & Lymphoma

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(98)

Sprache

Englisch
(98)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Hematology
(93)
Life Sciences & Biomedicine
(93)
Oncology
(93)
Science & Technology
(93)
Humans
(91)
Animals
(30)
Apoptosis - Drug Effects
(29)
Signal Transduction - Drug Effects
(25)
Cell Line, Tumor
(24)
Male
(24)
Female
(23)
Signal Transduction
(23)
Phosphatidylinositol 3-Kinases - Metabolism
(21)
Proto-Oncogene Proteins C-Akt - Metabolism
(21)
Antineoplastic Agents - Pharmacology
(17)
Apoptosis
(15)
Mice
(15)
Middle Aged
(15)
Cell Proliferation - Drug Effects
(14)
Leukemia, Lymphocytic, Chronic, B-Cell - Metabolism
(14)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Taylor & Francis Journals Complete
(98)
Taylor & Francis Current Content Access
(98)
MEDLINE
(95)

Menü

Weitere Dienste

Einstellungen

Management of adverse events associated with idelalisib treatment: expert panel opinion

G-protein coupled receptor 34 activates Erk and phosphatidylinositol 3-kinase/Akt pathways and functions as alternative pathway to mediate p185Bcr-Abl-induced transformation and leukemogenesis

Ibrutinib, idelalisib and obinutuzumab for the treatment of patients with chronic lymphocytic leukemia: three new arrows aiming at the target

Posttranscriptional regulation of the p85α adapter subunit of phosphatidylinositol 3-kinase in human leukemia cells

Novel phosphatidylinositol 3-kinase inhibitor BKM120 enhances the sensitivity of multiple myeloma to bortezomib and overcomes resistance

Prognostic significance of constitutive phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase phosphorylation in acute myeloid leukemia

Dual inhibition of phosphatidylinositol 3-kinase/mammalian target of rapamycin and mitogen activated protein kinase pathways in non-Hodgkin lymphoma

B-cell activating factor-receptor specific activation of tumor necrosis factor receptor associated factor 6 and the phosphatidyl inositol 3-kinase pathway in lymphoma B cells

NOTCH and phosphatidylinositide 3-kinase/phosphatase and tensin homolog deleted on chromosome ten/AKT/mammalian target of rapamycin (mTOR) signaling in T-cell development and T-cell acute lymphoblastic leukemia

Inhibition of class II phosphoinositide 3-kinase gamma expression by p185(Bcr-Abl) contributes to impaired chemotaxis and aberrant homing of leukemic cells

Posttranscriptional regulation of the p85α.alpha; adapter subunit of phosphatidylinositol 3-kinase in human leukemia cells

Overexpression of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase inhibits GM-CSF-dependent colony formation of CD34+ hematopoietic progenitor cells

Up-regulated autophagy by endogenous high mobility group box-1 promotes chemoresistance in leukemia cells

Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1

The role of PI3K inhibitors in the treatment of malignant lymphomas

BCR/ABL Regulation of PI-3 Kinase Activity

Activating somatic mutations in diffuse large B-cell lymphomas: lessons from next generation sequencing and key elements in the precision medicine era

Homoharringtonine inhibits the AKT pathway and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells

Pan-PI3Ki targets multiple B-ALL microenvironment interactions that fuel systemic and CNS relapse

Bryostatin Induces Protein Kinase C Modulation, Mcl-1 Up-Regulation and Phosphorylation of Bcl-2 Resulting in Cellular Differentiation and Resistance to Drug-induced Apoptosis in B-cell Chronic Lymphocytic Leukemia Cells

cAMP/PKA-mediated Regulation of Erythropoiesis

PI3-Kinase Regulates Survival of Chronic Lymphocytic Leukemia B-Cells by Preventing Caspase 8 Activation

Co-targeting intracellular pH and essential amino acid uptake cooperates to induce cell death of T-ALL/LL cells

Synergistic cytotoxicity of busulfan, melphalan, gemcitabine, panobinostat, and bortezomib in lymphoma cells

Leptin receptor expression and its association with PI3K/AKT signaling pathway in diffuse large B-cell lymphoma

Aktive Filter

Suchergebnisse filtern